Tabuk Pharmaceuticals
Saudi Arabia - RiyadhPharmaceutical
Focus: Tabuk Pharmaceuticals is a Saudi Arabia-based pharmaceutical manufacturer focused on small molecules with a primary therapeutic emphasis on neurology. The company operates at mid-market scale with 1,001-5,000 employees and has been established since 1994.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
PRIVATE
Employees
1001-5000
Open Jobs
5
Should You Work at Tabuk Pharmaceuticals?
AI assessmentTabuk represents a regional pharmaceutical player with stable operations but significant uncertainty regarding pipeline quality, financial health, and growth trajectory—suitable only for professionals prioritizing geographic stability or regional market experience over clear career advancement.
Why Work Here
- Established 30-year-old company with regional market leadership in the Middle East and potential growth in neurology therapeutics
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
8 total
LOE Risk
Protected
No near-term cliffs
Hiring
5 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Diabetic care Information, education, and communication intervention will be delivered by relevant and trained health animators working in chronic care clinic.
Self-careClinical Trials (1)
NCT04847856Diabetic Self-care Education at Primary Health Care in Saudi Arabia: A Pragmatic Randomized Trial in Tabuk
N/AHelp build intelligence for Tabuk Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.